Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
The **Prilocaine + epinephrine** is a combination drug comprised of the local anesthetic **prilocaine** and the vasoconstrictor **epinephrine**, most commonly used in dentistry and minor surgical interventions where rapid and prolonged local anesthesia is necessary. The principal mechanism involves **prilocaine** reversibly blocking sodium ion influx in neuronal membranes, thus inhibiting nerve conduction and producing anesthesia. **Epinephrine** acts as a vasoconstrictor, reducing local blood flow, delaying systemic absorption of prilocaine, prolonging anesthesia duration, and decreasing operative bleeding. This combination is often chosen for procedures requiring both efficient local pain control and minimal bleeding. Common indications include dental procedures, minor surgeries, and emergency interventions requiring hemostasis and anesthesia[1][3][5][7]. Key safety considerations include the risk of methemoglobinemia, a rare but serious side effect particularly linked to prilocaine[3].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on prilocaine + epinephrine.